Compare HOUR & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HOUR | COEP |
|---|---|---|
| Founded | 2015 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.3M | 100.4M |
| IPO Year | 2021 | N/A |
| Metric | HOUR | COEP |
|---|---|---|
| Price | $1.91 | $11.44 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 14.6K | ★ 41.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 128.57 | N/A |
| EPS | ★ 0.07 | N/A |
| Revenue | ★ $138,252,861.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $27.57 | ★ N/A |
| Revenue Growth | ★ 4.64 | N/A |
| 52 Week Low | $1.10 | $6.32 |
| 52 Week High | $6.84 | $21.41 |
| Indicator | HOUR | COEP |
|---|---|---|
| Relative Strength Index (RSI) | 53.00 | 40.10 |
| Support Level | $1.73 | $10.74 |
| Resistance Level | $1.95 | $15.98 |
| Average True Range (ATR) | 0.07 | 0.70 |
| MACD | 0.00 | 0.06 |
| Stochastic Oscillator | 23.01 | 25.88 |
Hour Loop Inc is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market, and sell products. Hour Loop predominantly operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The Company, as an Internet marketplace seller, sells products in multiple categories, including home/garden decor, toys, kitchenware, apparel, and electronics. It has only one segment, which is online retail (e-commerce).
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.